Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstoffkombination
AOK Baden-Württemberg Hauptverwaltung awarded €221K to GlaxoSmithKline GmbH&Co.KG for Healthcare & Medical in November 2024 — one of 299 awards this buyer has made, in line with its typical award size.
Buying agency
AOK Baden-Württemberg HauptverwaltungWinning supplier
GlaxoSmithKline GmbH&Co.KGContract description
Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstoffkombination Vilanterol und Umeclidiniumbromid
Related awards · AOK Baden-Württemberg Hauptverwaltung
299 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-761135-2024enercity AG€1.8M12 Dec 2024 Energy
- ocds-ted-223384-2025Blocher GmbH / blocher partners€1.5M07 Apr 2025 Professional Services
- ocds-ted-220707-2025IBK Ingenieurbüro Kaya GmbH€744K07 Apr 2025 Professional Services
Other wins · GlaxoSmithKline GmbH&Co.KG
81 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-262614-2025AOK Baden-Württemberg Hauptverwaltung€221K23 Apr 2025 Healthcare
- ocds-ted-325833-2026AOK Baden-Württemberg Hauptverwaltung€216K12 May 2026 Healthcare
- ocds-ted-223456-2026IKK classic€101 Apr 2026 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for AOK Baden-Württemberg Hauptverwaltung and GlaxoSmithKline GmbH&Co.KG — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back